World Trade Factory™

Wegovy, Ozempic Maker Novo's CEO Reacts to Pfizer Deal Win

Wegovy, Ozempic Maker Novo's CEO Reacts to Pfizer Deal Win

Novo Nordisk A/S Chief Executive Officer Mike Doustdar may have lost out to Pfizer Inc. in a $10 billion takeover battle for obesity drug developer Metsera Inc. But don’t expect him to give up on dealmaking any time soon as the Danish company seeks to regain lost ground in the booming weight-loss market.

Read Full Article →

📱 Tip: Tap the 🔗 Share icon in Safari and choose Add to Home Screen to install World Trade Factory.